Conformis Q2 Earnings Surpass Estimates On Higher Volumes And Royalties, License Revenue

  • Conformis Inc CFMS Q2 revenues more than doubled to $56.3 million, beating the consensus of $33 million.
  • The increase was driven primarily by elective procedure volumes and royalty & licensing revenue related to patent license settlement and development agreements.
  • Product revenue reached $15.2 million, +56% Y/Y (54% on a constant currency basis).
  • Royalty and licensing revenue of $41.1 million included $25 million in connection with the final milestone under the agreements with Stryker, Wright Medical, and Tornier. Conformis Hip System revenue was up 62% Y/Y to $0.9 million.
  • The total gross margin expanded from 57% to 84%.
  • The Company received 510(k) clearance for Identity Imprint Knee Replacement System, patient-specific instrumentation in Q2.
  • Conformis posted a net income of $38 million, or EPS of $0.21, beating the consensus of $0.04, and a turnaround from EPS loss of $(0.03) a year ago.
  • Cash and cash equivalents totaled $108.3 million.
  • FY21 Outlook: Conformis expects Q3 product revenue to improve sequentially to $15.5 million - $16.5 million.
  • It believes elective procedure volumes will continue to improve and approach 2019 levels in the fourth quarter as vaccines become more widely available and medical facilities recover from pandemic-related staffing impacts.
  • Mark Augusti, President & CEO, said"The environment for orthopedic surgical procedures has improved, and we believe procedure levels will continue to normalize. We remain cautiously optimistic about the second half of the year as we aim to get back to our 2019 revenue run rate."
  • Price Action: CFMS shares are up 9.80% at $1.68 during the premarket session on the last check Thursday.

Posted In: BriefsEarningsLong IdeasNewsPenny StocksGuidanceHealth CareMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.